EAN News

We would like to congratulate the winners of this year’s Investigator Award. The chosen winners have presented their work at the 4th EAN Congress in Lisbon this June. The Investigator Award consists of a free registration to the 5th EAN… Continue Reading

he Congress will begin each morning and afternoon with Plenary Sessions providing overviews of the phenomenology, pathophysiology, and current diagnostic and therapeutic strategies of various movement disorders. These sessions will be followed by Parallel Tracks, permitting participants to select specific diagnostic or therapeutic areas for more concentrated study.

RRFS special session: “Meet the experts and learn about clinical work and research (clinical and laboratory) around Europe” The special session of RRFS took place on Sunday, 17.06.2018 during the 4th EAN congress in Lisbon. The special session was held… Continue Reading

We congratulate the winners of the EAN Tournament during the 4th EAN Congress in Lisbon.
In two sessions, twelve young scientists presented their outstanding work. The EAN Tournament Prize consists of a certificate, travel, accommodation and registration to the 5th… Continue Reading

This year, the hospital visit of the Resident and Research Fellow Section (RRFS) of the European Academy of Neurology during the EAN congress was on Monday 18th June 2018. Sixty-seven residents and research fellows from 16 different countries mainly around Europe but also including countries from Africa went to the Hospital de Santa Maria which is one of the university hospitals of Lisbon.

The 2018 recipients, Prof. Amadou Gallo Diop (Senegal) and Prof. Riadh Gouider (Tunisia) have contributed exceptionally to develop neurology in Africa and to strengthen the relations between African neurology and EAN. The EAN Service Award comes with an official document and a personalized golden hammer.

The mission of EAN is ‘to promote excellence in neurology across Europe’. Therefore we need you, our colleagues, to become individual EAN members. Membership is not only for your own benefit, but also to accomplish our mission. As an individual member you can play an important role. By standing for election for the position as Delegate in the Assembly of Delegates you can become an influencer.

For August 2018, we have selected: Corvol JC, Artaud F, Cornier-Dequaire F, et al., for the DIGPD Study Group. Longitudinal analysis of impulse control disorders in Parkinson disease. Neurology 2018. doi:10.1212/WNL.0000000000005816. Impulse control disorders (ICDs) are frequent in Parkinson’s disease (PD) patients, and can have relevant consequences on social life. Whereas the association between treatment with dopamine agonists (DA) and the onset of ICDs is well known, there is controversy about the relationship with dose and duration of DA therapy.

The roots of clinical neurology can be traced back to Germany. With his ”Lehrbuch der Nervenkrankheiten des Menschen“ (textbook of human nervous diseases) 1840, Moritz Heinrich Romberg (1795 – 1873) established the foundation of clinical neurology as we know it today. His work was the first and for decades the only systematic representation of neurological diseases in Europe and America, bringing him international fame and esteem.

Prof. David B. Vodušek (DBV): Kindly illustrate the history, vision and mission of the EANM – European Association of  Nuclear Medicine to the readers of the EAN Pages. Prof. K. Muylle (KM): The European Association of Nuclear Medicine (EANM) is a professional non-profit medical association, incorporated in Vienna/Austria. The EANM’s vision is to optimise and advance science and education in nuclear medicine for the benefit of public health and humanity within the concept of personalised healthcare. The EANM acts as umbrella organisation for individuals as well as national societies.

Despite its large use, recommendations for the use of brain F-18 FDG-PET in clinical practice were still lacking. The European Academy of Neurology (EAN) and the European Association of Nuclear Medicine (EANM) promoted a concerted action with 7 specialists from the two Societies and a group of facilitators in order to make the point on this issue. Extensive literature review and analysis of available data led, together with expert opinion (Delphi consensus), to deliver these recommendations that cover practically all the main brain neurodegenerative conditions causing cognitive impairment.

The Guideline will address important areas of dementia management where the medical doctor plays a pivotal role, which includes treatment of epilepsy in dementia, pain in dementia, treatment with antipsychotics in dementia, vascular risk factors in dementia and systematic medical follow-up in dementia.

Prof. Elena Moro (EM): Dear Prof. Hallett, it is a great honor for me, as movement disorders specialist, to ask you few questions on behalf of the EAN members and for all EAN pages readers. In light of your Honorary Membership to the EAN, can you tell us what did make you choose “neurology” as the specialty to pursue? Prof. Mark Hallett (MH): I have been interested in the brain since I took a psychology course in high school.  I pursued neuroscience studies in college, but only decided to go into medicine about half way through college. 

Dear EAN Members, dear Colleagues, The 4th annual Congress of the European Academy of Neurology just held in Lisbon on June 16th - 19th was a spectacular event. More than 6,700 participants from 104 countries attended the meeting which covered the whole range of neurologic disorders in various formats, and offered altogether 42 scientific and 48 educational sessions. Besides several teaching courses and educational activities, the congress also comprised of 20 case-based workshops and interactive sessions, 7 hands-on courses, and 3 career development sessions.

For July 2018, we have selected: Thomalla G, Simonsen CZ, Boutitie G, et al., for the WAKE-UP Investigators. MRI-guided thrombolysis for stroke with unknown time of onset. NEJM May 16, 2018. doi:10.1056/NEJMoa1804355. Thrombolysis is currently performed in patients with acute ischemic stroke within a window of 4.5 hours since the symptoms’ onset. In about one third of the patients, the exact time of stroke onset is unknown, like in patients who wake up from sleeping.